Allergy

Autoimmune Diseases

Biosimilars

COVID-19

Cannabidiol (CBD)

Cardiology

Compounding

Continuous Glucose Monitoring

Dermatology

Diabetes

Digestive Health

Endocrinology

Eye Health

Generics

Headache and Migraine

Immunization

Infectious Disease

Influenza

Medical Devices

Mental and Behavioral Health

Neurology

Oncology

Pain Management

Pediatrics

Public Health

Rare Diseases

Respiratory

Rheumatology

Shingles

Substance Use Disorder

Technology and Data

Veterinary Pharmacy 

Women's Health

News

FDA Updates

Law and Advocacy

Technology Trends

Viewpoints

All News

Media

Around the Practice

In-Depth Insights

K-Casts

Script-Ed

Expert Interviews

Podcasts

Conferences

Conference Coverage

Conference Listing

Resources

Disease Awareness 

CME/CE

Partners

Publications

Drug Topics Journal

Total Pharmacy Journal

Events

Virtual Events

Total Pharmacy Solutions Summit

Business

Business Strategies

Patient Services

Pharmacy Inventory

Law and Regulations

All Business News

Practice Type

Independent Pharmacy

Chain Pharmacy

Specialty Pharmacy

Health System Pharmacy

Pharmacy Technicians

Subscribe

Articles

Nine pharmacists from 2 corporate locations in Wakefield and Westerly are seeking to join the Pharmacy Guild in an attempt to improve working conditions.

CVS Pharmacists in Rhode Island Petition to Unionize  

Kathy Campbell, PharmD, discusses why she believes wellness and proactive health are the future of pharmacy and the unique value they offer compared to traditional models.

Pharmacies Should Adopt Proactive Health, Wellness to Help Patients 

According to Kirollos Hanna, PharmD, although similarities exist between bispecific therapies in the myeloma space, health care providers should take special note of practical differences and nuances associated with each when operationalizing them at their site of care.

How Differences in Bispecific Therapies Impact Myeloma Treatment Operations

As the potential grows to use emerging bispecifics in earlier lines of myeloma therapy, so does the potential to induce better patient outcomes, said Kirollos Hanna, PharmD.

Myeloma Expert: Earlier Use of Bispecifics Can Improve Patient Outcomes

Advertise

Editorial

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Drug Topics

Facebook

Twitter

LinkedIn

Spotlight

How to strengthen your team’s role as a trusted clinical advisor

IDWeek

Important Steps You Need To Take Before Choosing A Pharmacy Software Vendor: Not All Review Sites Are Created Equal

Improving Care For Every Patient

Protecting Public Health Through Quality in Vaccine Inventory Storage

NCPA

Optimizing Treatment Strategies for Diabetes

Proper Injection Technique Ensures Positive Outcomes Among Patients With Diabetes

Special Report: Pharmacy Finances

The Evolving Landscape of Influenza Immunizations

The Power of Community: Pharmacists Share Their Experiences With Service Expansion

Rethink Medication Adherence With Sustainable Multidose Packaging

1rem

Authors

Oumaima Sahbani, PharmD, is a PGY-1 pharmacy resident at UConn John Dempsey Hospital at UConn Health, Farmington, CT 

Delafloxacin (Baxdela) for treatment of acute bacterial skin and skin structure infections including cellulitis, wound infection, major cutaneous abscess, and burn infection.

Delafloxacin (Baxdela) for Acute Bacterial Skin Infections